Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

PHASE4UnknownINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

September 30, 2003

Conditions
Meningococcal Disease; Meningococcal Meningitis
Interventions
BIOLOGICAL

· Meningococcal C conjugate vaccine; Meningococcal A/C Polysaccharide vaccine (partial dose)

Trial Locations (1)

OX3 9DU

University of Oxford, The Oxford Vaccine Group, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Chiron Corporation

INDUSTRY